The pharmaceutical company Eli Lilly is capping the out-of-pocket cost of insulin at $35 a month, a move that could help millions of Americans afford to pay for the life-saving medication. MiguelMValle explains the potential impact:
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Eli Lilly caps the cost of insulin at $35 a monthThe move puts the drugmaker in line with a popular provision in the Inflation Reduction Act that capped the medication’s cost for seniors on Medicare.
Weiterlesen »
Eli Lilly to cut insulin prices by 70%, cap monthly costs at $35The price reductions for the life-saving medication come amid criticism that unaffordable insulin may constitute a human rights abuse.
Weiterlesen »
Eli Lilly to cut insulin prices, cap costs at $35 for many people with diabetesAlthough insulin is relatively inexpensive to manufacture, the cost has been a problem for many Americans for years. At least 16.5% of people in the US who use it report rationing it because of cos…
Weiterlesen »
Eli Lilly to cut insulin prices, cap costs at $35 for many people with diabetes | CNNEli Lilly announced Wednesday a series of price cuts that would lower the price of the most commonly used forms of its insulin 70% and said it will automatically cap out-of-pocket insulin costs at $35 for people who have private insurance and use participating pharmacies.
Weiterlesen »
Eli Lilly to cut insulin prices by 70%, cap monthly cost at $35Some lawmakers have pushed for insulin prices to be capped. Eli Lilly said on Wednesday it will do so voluntarily.
Weiterlesen »
Eli Lilly Slashes Insulin Prices Up To 70% And Caps Out-Of-Pocket Costs To $35The pharma giant is making major cuts to the list prices of its insulin products.
Weiterlesen »